Aclaris Therapeutics, Inc.
ACRS· Nasdaq
ACRSAclaris Therapeutics, Inc.
Filed Nov 3, 2016 · 10-Q · 34 days after period end · 0001558370-16-009151
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | — | $0.00 | $0.00 |
| Net Income | -$10.69M | -$10.63M | -$2.66M |
| EPS Diluted | -$0.50 | -$5.12 | -$1.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aclaris Therapeutics, Inc. · CIK 1557746 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 3, 2016 · 34 d after period end
